In this issue:
Inaxaplin for proteinuric kidney disease in patients with two APOL1 variants
Kidney transplant rates and outcomes in adults with and without IDD
Intravenous sodium thiosulphate for calciphylaxis in patients with CKD
Prediction model for future eGFR in patients with type 2 diabetes and CKD
Effects of semaglutide on eGFR decline in patients at high cardiovascular risk
Association of the urine-to-plasma urea ratio with CKD progression
Pre-pregnancy eGFR and the risk of adverse pregnancy outcomes
Novel glucose-lowering drugs and the risk of AKI in routine care
Novel biomarker for differentiating functional from structural AKI
Sequential rituximab therapy in children with difficult-to-treat nephrotic syndrome
Please login below to download this issue (PDF)